Literature DB >> 10467996

Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation.

F Luzza1, A Contaldo, M Imeneo, M Mancuso, L Pensabene, L Giancotti, A M La Vecchia, M C Costa, P Strisciuglio, C Docimo, F Pallone, S Guandalini.   

Abstract

BACKGROUND: Little information is available about the relationships between Helicobacter pylori cytotoxin-associated protein (CagA) and clinicopathologic features in children. The purpose of this study was to test whether determining serum IgG antibodies to CagA is a useful tool for detecting more severe disease.
METHODS: One hundred twenty-seven consecutive children (age range, 0.75-17.8 years; median, 9.4 years) referred for gastroscopy were included in the study. Antral and corpus biopsies were taken for gastric histology and H. pylori detection. Major symptoms and endoscopic findings were recorded. A serum sample was drawn from each child and assayed for IgG antibodies CagA by a commercial enzyme-linked immunosorbent assay.
RESULTS: Sixty-three (50%) children had no evidence of H. pylori infection, 28 (22%) were H. pylori positive/CagA positive, and 36 (28%) were H. pylori positive/CagA negative. There were no differences in clinical diagnosis and occurrence of any predominant symptom according to H. pylori and CagA status. Findings of antral nodularity were more frequent (p = 0.003) in H. pylori-positive/CagA-positive children than in H. pylori-positive/CagA-negative children. The gastritis score was significantly higher in H. pylori-positive/CagA-positive children than in H. pylori-positive/CagA-negative children (5.7 +/- 1.9 vs. 3.8 +/- 1.6, respectively; p = 0.0003), either in the antral (p = 0.0002) or in the corpus (p = 0.001) mucosa. Inflammation (p = 0.0001) and activity (p = 0.0001) scores were both higher in H. pylori-positive/CagA-positive children than in H. pylori-positive/CagA-negative children, but the H. pylori density score was not significantly different (p = NS). In no case was normal gastric mucosa found in H. pylori-positive/ CagA-positive children. Lymphocytic gastritis (p = 0.0008) and lymphoid follicles (p = 0.000003) were a more frequent finding in H. pylori-positive children than in H. pylori negative children, irrespective of CagA status.
CONCLUSION: Testing for serum IgG to CagA detects higher grades of gastric inflammation among children with H. pylori infection. It may be useful in targeting H. pylori-positive/ CagA-positive children for antimicrobial therapy while reducing the need for endoscopy and gastric biopsy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467996     DOI: 10.1097/00005176-199909000-00012

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

1.  Prevalence of CagA and VacA antibodies in children with Helicobacter pylori-associated peptic ulcer compared to prevalence in pediatric patients with active or nonactive chronic gastritis.

Authors:  T Alarcón; M J Martínez; P Urruzuno; M L Cilleruelo; D Madruga; M Sebastian; D Domingo; J C Sanz; M López-Brea
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection.

Authors:  Javier Torres; Margarita Camorlinga-Ponce; Guillermo Perez-Perez; Leopoldo Muñoz; Onofre Muñoz
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  CagA positivity and its association with gastroduodenal disease in Turkish children undergoing endoscopic investigation.

Authors:  Semra Sökücü; Ayşe Tülin Ozden; Ozlem Durmaz Süoğlu; Berna Elkabes; Fikri Demir; Uğur Cevikbaş; Selim Gökçe; Günay Saner
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

4.  Infection with cagA-positive and cagA-negative types of Helicobacter pylori among children and adolescents with gastrointestinal symptoms in Latvia.

Authors:  I Daugule; I Rumba; L Engstrand; J Ejderhamn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-24       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.